Targeting the PI3K signaling cascade in PIK3CA mutated endometrial cancer in a primary human xenograft model.

被引：0
|
作者：
Bradford, Leslie Siriya
Rauh-Hain, Jose Alejandro
Clark, Rachel Marie
Groeneweg, Jolijn W.
Zhang, Ling
DiGloria, Celeste M.
Borger, Darrell R.
Growdon, Whitfield Board
Schorge, John O.
Foster, Rosemary
Rueda, Bo R.
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13564
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Inhibition of PI3K-AKT signaling precludes endometrial cancer growth in a primary human xenograft model harboring an oncogenic PIK3CA mutation
    Bradford, L.
    Zhang, L.
    Groeneweg, J.
    Borger, D.
    Engelman, J.
    Foster, R.
    Growdon, W.
    Schorge, J.
    Rueda, B.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S128 - S129
  • [2] Selective PI3K inhibition in wild type and PIK3CA mutated human gastrointestinal cancer
    Mueller, A.
    Bachmann, E.
    Linnig, M.
    Khillimberger, K.
    Galle, P. R.
    Moehler, M.
    ONKOLOGIE, 2011, 34 : 246 - 246
  • [3] Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example
    Zheng, Shutao
    He, Shuo
    Liang, Yan
    Tan, Yiyi
    Liu, Qing
    Liu, Tao
    Lu, Xiaomei
    MOLECULAR BIOMEDICINE, 2024, 5 (01):
  • [4] Generation of a novel PIK3CA mutated duodenal cancer mouse model and evaluation of PI3K inhibitor therapeutic effects
    Sugimori, Makoto
    Sugimori, Kazuya
    Kanemaru, Yushi
    Tsuchiya, Hiromi
    Suzuki, Yoshimasa
    Nakamori, Yoshinori
    Onodera, Sho
    Tsuyuki, Sho
    Hirotani, Akane
    Sawada, Atsushi
    Hirasawa, Kingo
    Nozaki, Akito
    Numata, Kazushi
    Kunisaki, Chikara
    Maeda, Shin
    CANCER SCIENCE, 2024, 115 : 1893 - 1893
  • [5] Targeting PI3K signaling in a xenograft model of nasopharyngeal carcinoma
    Merritt, David M.
    Smith, Pamela
    Thorley-Lawson, David A.
    CANCER RESEARCH, 2010, 70
  • [6] Analysis of PIK3CA mutations and PI3K signaling proteins as prognostic biomarkers for advanced gastric cancer
    Nishizuka, Satoshi S.
    Ito, Chie
    Kume, Kohei
    Iwaya, Takeshi
    Koeda, Keisuke
    Sasaki, Akira
    CANCER RESEARCH, 2017, 77
  • [7] PI3K expression and PIK3CA mutations are related to colorectal cancer metastases
    Zhu, Yu-Fen
    Yu, Bao-Hua
    Li, Da-Li
    Ke, Hong-Lin
    Guo, Xian-Zhi
    Xiao, Xiu-Ying
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (28) : 3745 - 3751
  • [8] Pilot investigation of the mutation profile of PIK3CA/PTEN genes (PI3K pathway) in grade 3 endometrial cancer
    Malentacchi, Francesca
    Turrini, Irene
    Sorbi, Flavia
    Projetto, Elisabetta
    Castiglione, Francesca
    Fambrini, Massimiliano
    Petraglia, Felice
    Pillozzi, Serena
    Noci, Ivo
    ONCOLOGY REPORTS, 2019, 41 (03) : 1560 - 1574
  • [9] PI3K expression and PIK3CA mutations are related to colorectal cancer metastases
    Yu-Fen Zhu
    World Journal of Gastroenterology, 2012, (28) : 3745 - 3751
  • [10] Tamoxifen instigates uterine cancer development by activating PI3K signaling and supersedes PIK3CA driver mutations
    Kubler, Kirsten
    Nardone, Agostina
    Anand, Shankara
    Gorvich, Daniel
    Droog, Marjolein
    Hermida-Prado, Francisco
    Akshi, Tara
    Feit, Avery S.
    Cohen, Gabriella
    Dackus, Gwen
    Pun, Matthew
    Kuang, Yanan
    Cha, Justin
    Miller, Mendy
    Gibson, William J.
    Paweletz, Cloud P.
    Van Allen, Eliezer M.
    van Leeuwen, Flora E.
    Nederlof, Petra
    Hollema, Harry
    Quang-De Nguyen
    Mourits, Marian J. E.
    Leshchiner, Ignaty
    Stewart, Chip
    Matulonis, Ursula A.
    Zwart, Wilbert
    Maruvka, Yosef E.
    Getz, Gad
    Jeselsohn, Rinath
    CANCER RESEARCH, 2022, 82 (04)
12345